Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03070210 · ClinicalTrials.gov registry record · NA

Clinical Trial to Evaluate the Endoscopic Ultrasound Guided Celiac Plexus Block for Treatment of Pain in Chronic Pancreatitis

A NA study, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
29
Enrollment target

NCT03070210: Completed NA study, sponsored by The Cleveland Clinic.

NCT03070210 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03070210, a NA study, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

AIM: To compare pain relief in patients randomly assigned to endoscopic ultrasound-guided celiac ganglia block (EUS-CGB) vs standard endoscopic ultrasound-guided celiac plexus block (EUS-CPB). METHODS: This is a single-center, double-blind, randomized parallel-group study to assess the efficacy of EUS-CPB vs. EUS-CGB in patients with painful chronic pancreatitis.

Primary Outcome

The primary endpoint will be pain relief at 1 week after the block, defined as a decrease of 3 or more points in the VAS scale measuring "average pain over past week".

Interventions

  • PROCEDURE EUS-celiac ganglia block (EUS-CGB)
  • PROCEDURE EUS-celiac plexus block (EUS-CPB)

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2017-01-25
Est. Completion 2019-08-01
Phase NA
The Cleveland Clinic

688 total trials

What the finished NCT03070210 record still lists

NCT03070210 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which EUS-celiac ganglia block (EUS-CGB) is the first listed.

NCT03070210 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03070210 about?

NCT03070210 is a clinical study titled "Clinical Trial to Evaluate the Endoscopic Ultrasound Guided Celiac Plexus Block for Treatment of Pain in Chronic Pancreatitis". AIM: To compare pain relief in patients randomly assigned to endoscopic ultrasound-guided celiac ganglia block (EUS-CGB) vs standard endoscopic ultrasound-guided celiac plexus block (EUS-CPB). METHODS: This is a single-center, double-blind, randomized parallel-group study to assess the efficacy of ...

What is the current status of trial NCT03070210?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2017-01-25. Estimated completion is 2019-08-01.

What interventions are being tested in trial NCT03070210?

The interventions under investigation include: EUS-celiac ganglia block (EUS-CGB) (PROCEDURE), EUS-celiac plexus block (EUS-CPB) (PROCEDURE).

Who is sponsoring clinical trial NCT03070210?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03070210's enrollment target sits among peer trials

29 1702nd of 2000 higher than 297 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03070210, the US trial registry maintained by the National Library of Medicine. NCT03070210 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.